Interferon-induced sarcoidosis

Mittie K. Doyle, Ruth E Berggren, Jeanette H. Magnus

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Rheumatologists are increasingly asked to see patients with hepatitis C who exhibit a variety of clinical and serologic features that mimic systemic rheumatic disease. Treatment with interferons, now the standard of care, can precipitate a variety of inflammatory conditions, including sarcoidosis. We present a case of a 59-year-old former intravenous drug user who developed systemic sarcoidosis while receiving interferon alpha and ribavirin for the treatment of chronic hepatitis C. Because interferons are increasingly prescribed by specialists in a variety of disciplines, rheumatologists should be aware of their potential to induce sarcoidosis as well as various autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)241-248
Number of pages8
JournalJournal of Clinical Rheumatology
Volume12
Issue number5
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Sarcoidosis
Interferons
Ribavirin
Chronic Hepatitis C
Standard of Care
Hepatitis C
Drug Users
Rheumatic Diseases
Interferon-alpha
Autoimmune Diseases
Therapeutics
Rheumatologists

Keywords

  • Autoimmunity
  • Hepatitis C
  • Interferon
  • Sarcoidosis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Interferon-induced sarcoidosis. / Doyle, Mittie K.; Berggren, Ruth E; Magnus, Jeanette H.

In: Journal of Clinical Rheumatology, Vol. 12, No. 5, 10.2006, p. 241-248.

Research output: Contribution to journalArticle

Doyle, Mittie K. ; Berggren, Ruth E ; Magnus, Jeanette H. / Interferon-induced sarcoidosis. In: Journal of Clinical Rheumatology. 2006 ; Vol. 12, No. 5. pp. 241-248.
@article{86d1dc9a819e41d799bb32be663891cb,
title = "Interferon-induced sarcoidosis",
abstract = "Rheumatologists are increasingly asked to see patients with hepatitis C who exhibit a variety of clinical and serologic features that mimic systemic rheumatic disease. Treatment with interferons, now the standard of care, can precipitate a variety of inflammatory conditions, including sarcoidosis. We present a case of a 59-year-old former intravenous drug user who developed systemic sarcoidosis while receiving interferon alpha and ribavirin for the treatment of chronic hepatitis C. Because interferons are increasingly prescribed by specialists in a variety of disciplines, rheumatologists should be aware of their potential to induce sarcoidosis as well as various autoimmune diseases.",
keywords = "Autoimmunity, Hepatitis C, Interferon, Sarcoidosis",
author = "Doyle, {Mittie K.} and Berggren, {Ruth E} and Magnus, {Jeanette H.}",
year = "2006",
month = "10",
doi = "10.1097/01.rhu.0000240035.67652.9d",
language = "English (US)",
volume = "12",
pages = "241--248",
journal = "Journal of Clinical Rheumatology",
issn = "1076-1608",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Interferon-induced sarcoidosis

AU - Doyle, Mittie K.

AU - Berggren, Ruth E

AU - Magnus, Jeanette H.

PY - 2006/10

Y1 - 2006/10

N2 - Rheumatologists are increasingly asked to see patients with hepatitis C who exhibit a variety of clinical and serologic features that mimic systemic rheumatic disease. Treatment with interferons, now the standard of care, can precipitate a variety of inflammatory conditions, including sarcoidosis. We present a case of a 59-year-old former intravenous drug user who developed systemic sarcoidosis while receiving interferon alpha and ribavirin for the treatment of chronic hepatitis C. Because interferons are increasingly prescribed by specialists in a variety of disciplines, rheumatologists should be aware of their potential to induce sarcoidosis as well as various autoimmune diseases.

AB - Rheumatologists are increasingly asked to see patients with hepatitis C who exhibit a variety of clinical and serologic features that mimic systemic rheumatic disease. Treatment with interferons, now the standard of care, can precipitate a variety of inflammatory conditions, including sarcoidosis. We present a case of a 59-year-old former intravenous drug user who developed systemic sarcoidosis while receiving interferon alpha and ribavirin for the treatment of chronic hepatitis C. Because interferons are increasingly prescribed by specialists in a variety of disciplines, rheumatologists should be aware of their potential to induce sarcoidosis as well as various autoimmune diseases.

KW - Autoimmunity

KW - Hepatitis C

KW - Interferon

KW - Sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=33749527090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749527090&partnerID=8YFLogxK

U2 - 10.1097/01.rhu.0000240035.67652.9d

DO - 10.1097/01.rhu.0000240035.67652.9d

M3 - Article

C2 - 17023810

AN - SCOPUS:33749527090

VL - 12

SP - 241

EP - 248

JO - Journal of Clinical Rheumatology

JF - Journal of Clinical Rheumatology

SN - 1076-1608

IS - 5

ER -